- Home
- / ZIOPHARM Oncology
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
ZIOPHARM Oncology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.7
2022-03-30
Market Capitalization
$187.1 M
2022-03-30
Revenue
$5 K
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 667.0K | 800.0K | 800.0K | 1.4M | 4.3M | 6.9M | 6.4M | 146.0K | 398.0K | 2.9M | 5.0K | 10.0K | 5.0K | |
| Revenue growth, % | 71.6% | 215.5% | 58.4% | |||||||||||
| General and administrative expense | 15.0M | 19.5M | 15.7M | 12.2M | 17.6M | 14.4M | 14.8M | 19.9M | 27.7M | 27.6M | 13.1M | 12.2M | 4.5M | 2.9M |
| Operating expense total | 72.1M | 103.0M | 58.5M | 44.9M | 124.4M | 172.2M | 59.9M | 54.1M | 80.4M | 38.2M | 4.8M | 4.2M | ||
| Depreciation and amortization | 7.0K | |||||||||||||
| EBIT | (71.4M) | (102.2M) | (57.7M) | (43.5M) | (120.1M) | (165.3M) | (53.5M) | (53.9M) | (80.4M) | (77.5M) | (35.1M) | (34.3M) | (4.8M) | (4.2M) |
| EBIT margin, % | -10704.6% | -12771.1% | -7214.1% | -3168.2% | -2772.4% | -2409.4% | -837.3% | -36921.9% | -1210.5% | -48120.0% | -84500.0% | |||
| Interest expense | 1.9M | |||||||||||||
| Net Income | (63.8M) | (96.1M) | (57.1M) | (31.8M) | (120.1M) | (165.3M) | (54.3M) | (53.1M) | (80.0M) | (78.8M) | (37.7M) | (35.1M) | (4.7M) | (4.2M) |
| EPS | (0.2) | (2.0) | (2.9) | (2.2) |